Incyte (INCY) Change in Inventory (2012 - 2026)
Incyte's (INCY) quarterly Change in Inventory came in at $11.9 million in Q2 2026, down 39.16% YoY from $19.5 million in Q2 2025, and down 2.84% on a QoQ basis from $12.2 million in Q1 2026.
Analysis
Incyte (INCY) Change in Inventory (2012 - 2026) Analysis & Trends
Incyte (INCY) has 15 years of Change in Inventory data on file, last reported at $11.9 million in Q2 2026.
- Quarterly Change in Inventory fell 39.16% year-over-year to $11.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $34.5 million (down 61.97% YoY) and the FY2025 annual result came in at $58.5 million, down 54.16% from the prior year.
- Change in Inventory declined to $11.9 million in Q2 2026, from $12.2 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $93.0 million in Q4 2023 to a low of $4.9 million in Q4 2025.
- A 5-year average of $24.9 million and a median of $19.8 million in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory surged 15552.78% — and 2025, when it slumped 85.83%.
- Tracing INCY's Change in Inventory over 5 years: stood at $19.2 million in 2022, then soared by 384.46% to $93.0 million in 2023, then sank by 63.12% to $34.3 million in 2024, then tumbled by 85.83% to $4.9 million in 2025, then soared by 144.47% to $11.9 million in 2026.
- The last three Change in Inventory figures came in at $11.9 million (Q2 2026), $12.2 million (Q1 2026), and $4.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 11.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.88 Mn |
| Mar 31, 2026 | 12.23 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Sep 30, 2025 | 5.56 Mn |
| Jun 30, 2025 | 19.53 Mn |
| Mar 31, 2025 | 28.57 Mn |
| Dec 31, 2024 | 34.28 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 27.78 Mn |
| Mar 31, 2024 | 57.20 Mn |
| Dec 31, 2023 | 92.96 Mn |
| Sep 30, 2023 | 23.76 Mn |
| Jun 30, 2023 | 20.12 Mn |
| Mar 31, 2023 | 33.32 Mn |
| Dec 31, 2022 | 19.19 Mn |
| Sep 30, 2022 | 11.13 Mn |
| Jun 30, 2022 | 23.29 Mn |
| Mar 31, 2022 | 13.90 Mn |
| Dec 31, 2021 | 4.75 Mn |
| Sep 30, 2021 | -72,000.00 |